Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 22.66% is in line with its 5-year average of 21.06%, near the high end of its 5-year range (7.04%–24.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.47% below its 12-month average of 22.77%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 22.66%.
RETURN ON EQUITY (ROE)
22.66%
RETURN ON EQUITY (ROE) AVG TTM
22.77%
RETURN ON EQUITY (ROE) AVG 3Y
22.65%
RETURN ON EQUITY (ROE) AVG 5Y
21.06%
RETURN ON EQUITY (ROE) AVG 10Y
16.29%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.47%
CURRENT VS 3Y AVG
+0.03%
CURRENT VS 5Y AVG
+7.61%
CURRENT VS 10Y AVG
+39.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.51%
median of 459 covered companies
CURRENT VS SECTOR MEDIAN
+158.84%
vs the sector median at left
IRadimed Corporation
Market Cap
$1.10B
Return on Equity (ROE)
22.66%
TTM Avg
22.77%
3Y Avg
22.65%
5Y Avg
21.06%
Market Cap
$1.11B
Return on Equity (ROE)
10.23%
TTM Avg
17.11%
3Y Avg
18.25%
5Y Avg
14.55%
Market Cap
$1.14B
Return on Equity (ROE)
-244.91%
TTM Avg
-17.45%
3Y Avg
-30.16%
5Y Avg
-48.76%
Market Cap
$1.12B
Return on Equity (ROE)
-39.54%
TTM Avg
-24.09%
3Y Avg
36.77%
5Y Avg
36.77%
Market Cap
$1.15B
Return on Equity (ROE)
-4.13%
TTM Avg
-0.56%
3Y Avg
-8.16%
5Y Avg
-7.12%
Market Cap
$1.16B
Return on Equity (ROE)
2.51%
TTM Avg
3.60%
3Y Avg
0.50%
5Y Avg
-7.05%
Market Cap
$1.05B
Return on Equity (ROE)
-4.51%
TTM Avg
-33.13%
3Y Avg
-42.62%
5Y Avg
-42.62%
Market Cap
$1.04B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$1.02B
Return on Equity (ROE)
-0.69%
TTM Avg
-24.98%
3Y Avg
-8.92%
5Y Avg
-2.80%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRadimed Corporation (IRMD) | $1.10B | 22.66% | 22.77% | 22.65% | 21.06% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 10.23% | 17.11% | 18.25% | 14.55% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | -244.91% | -17.45% | -30.16% | -48.76% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.12B | -39.54% | -24.09% | 36.77% | 36.77% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.15B | -4.13% | -0.56% | -8.16% | -7.12% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 2.51% | 3.60% | 0.50% | -7.05% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.05B | -4.51% | -33.13% | -42.62% | -42.62% |
| Teladoc Health, Inc. (TDOC)vs › | $1.04B | -13.54% | -40.81% | -170.75% | -114.78% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | -0.69% | -24.98% | -8.92% | -2.80% |
| Immatics N.V. (IMTX)vs › | $1.02B | -52.47% | -18.98% | -16.96% | -116.25% |
ROE
22.7%
ROA
20.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 22.66% |
| 2026-03-31 | 23.97% |
| 2025-12-31 | 23.76% |
| 2025-09-30 | 21.54% |
| 2025-06-30 | 21.91% |
| 2025-03-31 | 21.97% |
| 2024-12-31 | 22.15% |
| 2024-09-30 | 22.33% |
| 2024-06-30 | 23.40% |
| 2024-03-31 | 23.55% |
| 2023-12-31 | 24.07% |
| 2023-09-30 | 21.90% |
| 2023-06-30 | 21.29% |
| 2023-03-31 | 21.37% |
| 2022-12-31 | 17.41% |
| 2022-09-30 | 18.70% |
| 2022-06-30 | 18.51% |
| 2022-03-31 | 16.67% |
| 2021-12-31 | 12.92% |
| 2021-09-30 | 8.94% |
| 2021-06-30 | 7.04% |
| 2021-03-31 | 1.56% |
| 2020-12-31 | 2.23% |
| 2020-09-30 | 6.54% |
| 2020-06-30 | 9.17% |
| 2020-03-31 | 16.46% |
| 2019-12-31 | 17.35% |
| 2019-09-30 | 15.64% |
| 2019-06-30 | 17.06% |
| 2019-03-31 | 16.37% |
| 2018-12-31 | 15.03% |
| 2018-09-30 | 11.92% |
| 2018-06-30 | 7.11% |
| 2018-03-31 | 4.60% |
| 2017-12-31 | 1.52% |
| 2017-09-30 | 4.53% |
| 2017-06-30 | 9.03% |
| 2017-03-31 | 14.67% |
| 2016-12-31 | 22.62% |
| 2016-09-30 | 27.67% |
| 2016-06-30 | 30.86% |
| 2016-03-31 | 28.46% |
| 2015-12-31 | 23.58% |
| 2015-09-30 | 19.19% |
| 2015-06-30 | 15.01% |
| 2015-03-31 | 13.13% |
| 2014-12-31 | 9.81% |
| 2014-09-30 | 11.18% |
| 2014-06-30 | 31.19% |
| 2014-03-31 | 29.72% |
| 2013-12-31 | 35.72% |
